Held at the University of Wollongong, the 2023 Australian Statistical Conference theme was 'Statisticians in society', acknowledging the important contributions that statisticians make as technical experts and communicators in an increasingly data-dependent world.
Over 200+ health system leaders gathered at the Value-Based Health Care Congress at QUT Gardens Point on 26-27 October to discuss the global Value-Based Health Care movement (VBHC), and what it means in the context of Australia.
Dr Michelle Allen, AusHSI Research Fellow - Implementation Science, shares her perspective on the healthcare system and how shifting the status quo can deliver real improvements.
If you've ever questioned typical scientific practice and wondered how it could be improved, then join us at AIMOS 2023. We can guarantee you will learn a lot about the workings of science and how we can all improve it.
The AusHSI statistics team has developed two new Shiny applications to help researchers synthesise evidence for literature reviews and health economic modelling.
Smoking prevalence across Australia has not substantially declined in the past decade. My PhD project aims to reduce smoking in Queensland by supporting Quitline users to successfully quit smoking through improved uptake and engagement with the service.
World Bronchiectasis Day is held on 1 July and aims to raise awareness, share knowledge, and discuss ways to reduce the burden of bronchiectasis for patients and their families worldwide. Learn how the Cough and Airways Research group at AusHSI is focused on improving the lung health and quality of life of children with bronchiectasis.
It has now been shown that, if bronchiectasis is picked up early in children, appropriate management can reverse the radiological airway damage in some patients. It is therefore crucial that children are diagnosed early and receive the best medical care.
Many parents have not heard of bronchiectasis until their child has been diagnosed. It is often at this point that parents seek out further information, and our respiratory research group has developed several resources to support families.
Bronchiectasis is a chronic respiratory disease which currently has no licensed medication specific to the condition. The BronchiEctasis Trial Testing ERdosteine investigates a bronchiectasis-specific pharmaceutical treatment aiming to improve patient outcomes.
